|

Issues

The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration Regarding Unique Device Identification for Medical Devices Docket No. FDA-2011–N–0090

AHRMM Member Advisory: Medical Device Tax Next Steps

IRS Issues Final Rule Implementing Medical Device Excise Tax

FDA Releases Proposed Rule on Unique Device System for Medical Devices

AHRMM Leading Practice Statement on Supply Chain Integration

AHRMM Statement on Comparative Effectiveness

AHRMM Statement of Concern over Device Supplier Actions that Inhibit Price Transparency

AHRMM Statement on Pricing Transparency

Leveraging Supply Chain Leadership White Paper 

Navigating the Economic Storm White Paper

Pandemic Flu Resources

Reprocessing Advisory

Initiatives

AHRMM, AHE, and ASHE Co-Develop Practical, Hands-On Resource to Help Hospitals Reach Their Sustainability Goals

AHRMM and Other Healthcare Organizations Urge IRS to Prohibit Device Companies from Passing Excise Tax to Providers

Advancing Patient Safety Coalition's Letter to Sen. Merkley in Support of the Ensuring Safe Medical Devices for Patients Bill

Academic Council for Healthcare Supply Chain Research

Benchmarking

Disaster Preparedness

Healthcare Supply Chain Data Standards

Institute of Medicine’s Six Aims for Improvement

Practice Greenhealth

Request to the Office of Management and Budget for an Expeditious Release of the Food and Drug Administration’s Proposed Rule on Unique Device Identifiers